These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28886115)

  • 1. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
    Gui B; Hsieh CL; Kantoff PW; Kibel AS; Jia L
    PLoS One; 2017; 12(9):e0184166. PubMed ID: 28886115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
    Wan X; Huang W; Yang S; Zhang Y; Zhang P; Kong Z; Li T; Wu H; Jing F; Li Y
    Int J Biochem Cell Biol; 2016 Oct; 79():249-260. PubMed ID: 27594411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
    Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
    Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
    Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
    Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
    Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
    Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
    Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
    Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
    Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer.
    Savoy RM; Chen L; Siddiqui S; Melgoza FU; Durbin-Johnson B; Drake C; Jathal MK; Bose S; Steele TM; Mooso BA; D'Abronzo LS; Fry WH; Carraway KL; Mudryj M; Ghosh PM
    Endocr Relat Cancer; 2015 Jun; 22(3):369-86. PubMed ID: 25759396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
    Sun T; Wang X; He HH; Sweeney CJ; Liu SX; Brown M; Balk S; Lee GS; Kantoff PW
    Oncogene; 2014 May; 33(21):2790-800. PubMed ID: 23770851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
    Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
    World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
    Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.
    Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC
    Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
    Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
    Guan H; You Z; Wang C; Fang F; Peng R; Mao L; Xu B; Chen M
    Cancer Med; 2019 Apr; 8(4):1474-1485. PubMed ID: 30784214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
    Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.